Search
for

    Sort by

    Research 781–810 of 1000+

    1. Finasteride in Androgenic Alopecia Journal of the Dermatology Nurses’ Association · 2016 · 1 citations
    2. Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis European Urology Focus · 2026
    3. Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis Cancers · 2025
    4. Pharmacology of antiandrogens Journal of Steroid Biochemistry · 1986 · 97 citations
    5. Should Finasteride Be Routinely Given Preoperatively for TURP? ISRN Urology (Print) · 2013 · 2 citations
    6. Is dehydroepiandrosterone a hormone? Journal of Endocrinology · 2005 · 403 citations
    7. Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Cancer research · 2011 · 402 citations
    8. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men Cell Stem Cell · 2020 · 139 citations
    9. Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer Endocrine Related Cancer · 2010 · 30 citations
    10. CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? The Journal of Sexual Medicine · 2013 · 29 citations
    11. Male pattern baldness and prostate cancer risk in a population-based case–control study Cancer epidemiology · 2010 · 29 citations
    12. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study Archives of Cardiovascular Diseases · 2019 · 17 citations
    13. The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor Tumor Biology · 2021 · 16 citations
    14. Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors Chemical and Pharmaceutical Bulletin · 2005 · 13 citations
    15. Factors associated with early-onset androgenetic alopecia: A scoping review PLOS ONE · 2024
    16. Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment Journal of The American Academy of Dermatology · 2013
    17. Squamous metaplasia of the prostate and diffuse alopecia in a 13-year-old castrated dog due to chronic ingestion of exogenous estradiol Open Repository and Bibliography (University of Liège) · 2012
    18. A cornerstone of hematological science Community oncology · 2012
    19. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    20. Propecia: The Goose That Lays the Golden Eggs Skinmed · 2005
    21. Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2013 · 34 citations
    22. Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France BMC Cancer · 2014 · 27 citations
    23. Beeinflussen Medikamente gegen das benigne Prostatasyndrom Stimmung oder Kognition? Der Urologe · 2019 · 3 citations
    24. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses PLoS medicine · 2024
    25. Current Literature Review The Journal of Sexual Medicine · 2013
    26. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review European Urology · 2023 · 710 citations
    27. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers Cancers · 2022 · 10 citations
    28. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    29. Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors Instituto Politécnico do Porto · 2025
    30. Experimental Assessment of 3-<i>meta</i>-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-α-Reductase Inhibitors <i>in silico</i> and <i>in vivo</i> Models Bioorganičeskaâ himiâ · 2023